INVESTIGADOR

Dr. Salvador López Gil

Departamento de Nefrología, Instituto Nacional de Cardiología, México

Historial académico

El Dr. Salvador López Gil, obtuvo el grado de Licenciado en Médico Cirujano por la Universidad La Salle (ULSA). Posteriormente, ingresó a la Universidad Nacional Autónoma de México (UNAM), donde realizó sus estudios en las  especialidades de Medicina Interna y Nefrología; de igual manera, en la misma institución cursó el Diplomado Universitario en Ecocardiografía y Ultrasonografía en Áreas Críticas.

Publicaciones

  • WCN24-1721 Exploring CXCL13 levels in acute antibody-mediated rejection in renal transplantation: an integrated experimental and bioinformatics approach. Kidney International Reports. 2024
  • WCN24-868 MicroRNAs as biomarkers of acute antibody-mediated rejection in renal transplant patients. Kidney International Reports. 2024
  • WCN24-2240 The impact of intradialytic exercise and dialysate temperature on uremic toxins clearance in hemodiafiltration patients. Kidney International Reports. 2024
  • WCN24-2232 Utility of intermittent hemodiafiltration in hemodynamically unstable post cardiac surgery patients. Kidney International Reports. 2024
  • WCN24-2177 on the right way to decongestion, from vexus to the plasma refilling rate: a twosided story. Kidney International Reports. 2024
  • WCN24-1292 Impact of plasma refill rate/ultrafiltration rate ratio on hemodynamic stability during hemodialysis in patients with acute kidney injury. Kidney International Reports. 2024
  • Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide. Nephron. 2024
  • Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy. World Journal of Nephrology. 2024
  • Neurocognitive Function with Conventional Hemodialysis versus Post-Dilution Hemofiltration as Initial Treatment in ESKD Patients: A Randomized Controlled Trial – The DA-VINCI Study. Blood Purification. 2024
  • Removal of Middle Molecules and Dialytic Albumin Loss: A Cross-over Study of Medium Cutoff and High-Flux Membranes with Hemodialysis and Hemodiafiltration. Kidney360. 2023
  • Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study. Journal of Cardiac Failure. 2023
  • Venous excess ultrasound score and acute kidney injury in patients with acute coronary syndrome. European Heart Journal. Acute Cardiovascular Care. 2023
  • Bilateral Nephromegaly and Spontaneous Tumor Lysis Syndrome as an Initial Manifestation of Pre-T Acute Lymphoblastic Leukemia: Case Report and Review of the Literature. Research Square. 2023
  • Recurrence plot analysis of heart rate variability in end-stage renal disease treated twice-weekly by hemodialysis with or without intradialytic hypotension. The European Physical Journal Special Topics. 2022
  • Active fluid management in Tassin/France of the 21st century and outcomes. Kidney International. 2022
  • Intraocular Pressure Changes during Hemodiafiltration with Two different Concentrations of Sodium in the Dialysate. Biology. 2021
  • What Is the Optimal Sodium Concentration in the Dialysate?. Kidney and Dialysis.2021
  • Chronic Fluid Overload Assessment in Hemodialysis Patients Close to Dry Weight. Blood Purification. 2020
  • El ABC de la Medicina Interna 2019. Capítulo 15. Lesión Renal Aguda. Editorial Alfil. 2019
  • El ABC de la Medicina Interna 2016: Anticuerpos Monoclonales: Sección 8, Capítulo 8.2: Cáncer de Células Renales. 1era Edición. Editorial Alfil. 2016
  • El ABC de la Medicina Interna 2015, Capítulo 22: Abordaje de la Hipertensión Secundaria págs. 159-162. Editorial Alfil. 2015 
  • Effect of Hemodiafiltration Plus Medium Cut – Off Membranes on Uremic Toxins Removal. Departamento de Nefrología. Instituto Nacional de Cardiología. Renal Research Institute N.Y.
  • Afasia motora transitoria por encefalopatía hipóxica: papel de la ínsula [Transitory motor aphasia caused by hypoxic encephalopathy: role of the insula]. Anales Médicos de la Asociación Médica del Centro Médico ABC. 2013
  • Efecto de Alopurinol o Febuxostat en la Prevención de Lesión Renal Aguda Inducida por Medio de Contraste. Ensayo Clínico Aleatorizado Doble Ciego Controlado por Placebo. Departamento de Nefrología. Instituto Nacional de Cardiología Ignacio Chávez. Ciudad de México 
es_MXES